SAM
TEVA icon

Southpaw Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Southpaw Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-717,100
Closed -$6.92M – 1
2020
Q4 		$6.92M Hold
717,100
– – 100% 1
2020
Q3 		$6.46M Hold
717,100
– – 44.29% 1
2020
Q2 		$8.84M Sell
717,100
-270,000
-27% -$3.05M 21.91% 2
2020
Q1 		$8.87M Buy
987,100
+27,100
+3% +$278K 8.28% 3
2019
Q4 		$9.41M Buy
960,000
+460,000
+92% +$4.11M 14.79% 3
2019
Q3 		$3.44M Buy
+500,000
New +$3.83M 3.11% 8

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return